CJC / IPA Blend
CJC / IPA Blend, 10mg from $60. A GHRH analog and a GH secretagogue in one vial. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This blend pairs CJC-1295 with ipamorelin. Both relate to growth hormone, but they act at different receptors. CJC-1295 copies GHRH, the hormone that signals release. Ipamorelin acts at a separate receptor called GHS-R. Research has measured what happens when both are present compared to either one alone. Pairing a GHRH analog with a secretagogue is a common combination in growth hormone research.
Dual-component blend: GHRH-R agonist (CJC-1295, Modified GRF 1-29) + GHSR-1a agonist pentapeptide (Ipamorelin)
CJC-1295 (Modified GRF 1-29) is the GHRH receptor agonist component. It binds GHRH-R on pituitary somatotrophs, with cAMP production and GH synthesis measured. The four DPP-IV-resistant amino acid substitutions extend bioavailability to ~30 minutes, giving a longer window of GHRH-R activation per administration.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | CJC / IPA Blend |
| Category | Peptide Blends |
| Lot Number | MBP-8445 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!